Triangle cell therapy startup Inceptor Bio closes $37M in Series A funding
Cell and gene therapy startup Inceptor Bio, which raised $26 million in seed capital not long ago, has added more than $37 million in Series A funding.
Read MorePosted by Jason Parker | May 19, 2022
Cell and gene therapy startup Inceptor Bio, which raised $26 million in seed capital not long ago, has added more than $37 million in Series A funding.
Read MorePosted by Shannon Cuthrell | Sep 22, 2017
It took years of meticulous organizing, thoughtful strategy and a year-long beta to bring Dropsource‘s mobile app development tool to launch. Once it had established a recognized brand among mobile developers and received solid validation from beta users, Dropsource came out of stealth mode this summer ready to dominate...
Read More